Kymera Therapeutics, Inc. earnings per share and revenue

KYMR earnings per share for the last quarter are -0.88 USD whereas the estimation was -0.77 USD which accounts for -13.58% surprise. Company revenue for the same period amounts to 7.39 M USD despite the estimated figure of 14.36 M USD. Estimated earnings per share for the next quarter are -0.90 USD, and revenue is expected to reach 11.38 M USD. Also watch annual changes over time to get a bigger picture of KYMR earnings per share and revenue dynamics.